Caption Management, LLC Clovis Oncology, Inc. Put Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 16, 2021	BUY	$5.02 - $7.05 $419,169 - $588,675	83,500 Added 80.29%	187,500 $1.09 Million
Q1 2020 May 15, 2020	SELL	$3.77 - $11.0 $829,400 - $2.42 Million	-220,000 Reduced 67.9%	104,000 $662,000
Q4 2019 Feb 13, 2020	SELL	$3.0 - $16.43 $379,500 - $2.08 Million	-126,500 Reduced 28.08%	324,000 $3.38 Million
Q3 2019 Nov 14, 2019	BUY	$3.93 - $15.35 $1.53 Million - $5.99 Million	390,500 Added 650.83%	450,500 $1.77 Million
Q2 2019 Aug 13, 2019	SELL	$12.81 - $25.67 $1.08 Million - $2.16 Million	-84,100 Reduced 58.36%	60,000 $892,000
Q1 2019 May 14, 2019	BUY	$17.66 - $30.28 $2.54 Million - $4.36 Million	144,100 New	144,100 $3.58 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.